Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Nephrolithiasis: early-phase trial registry
10 of 17 indexed Nephrolithiasis trials are currently recruiting, with more weight in Phase 1-2.
Corpus placement: #1,004 of 28,707 conditions by registered trial count.
17 US clinical trials · 10 currently recruiting · #1,004 of 28,707 conditions by registered trial count
Nephrolithiasis: 17 US clinical trials tracked, 10 recruiting.
Nephrolithiasis is the subject of 17 registered US clinical trials on ClinicalTrials.gov, 10 of them currently open to new participants. 0 are in Phase 3-4 (later-stage) and 2 in Phase 1-2 (earlier-stage). The most active sponsor is University of Alabama at Birmingham, running 3 of these trials.
Enrollment posture brief
Registry condition nephrolithiasis
OPEN 10 | RECR 59% | LATE 0 | EARLY 2 | RANK #1004 | SPON 3
Volume-matched condition peers
Nearest open-share peer: HPV Positive Oropharyngeal Squamous Cell Carcinoma (59% recruiting · 17 trials)
Nephrolithiasis lists 10 open slots (59% of 17 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Nephrolithiasis on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Nephrolithiasis is recruiting above its size-band peers.
10 of 17 indexed trials (58.8%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
-
One sponsor concentrates Nephrolithiasis research.
University of Alabama at Birmingham accounts for 3 of 17 trials (17.6%). 14 distinct sponsors appear on at least one study for this condition label.
-
Typical Nephrolithiasis enrolment sits around 85 participants.
Median target enrolment is 85 among the 17 trials that report a genuine target (sentinel values excluded). 10 of those (58.8%) plan for fewer than 100 participants.
-
Nephrolithiasis research is mostly interventional.
15 interventional and 2 observational studies make up this index (88.2% interventional). Study type is sponsor-reported on ClinicalTrials.gov.
Open and recent trials
17 total, page 1 of 1
Serum Endotoxin Assay to Predict the Development of Postoperative Infectious Complications and Systemic Inflammatory Response Following Percutaneous Nephrolithotomy.
University of Miami
NCT04669886
ClearPetra™ Vacuum-assisted Ureteral Access Sheath vs Traditional Approach
University of Kansas Medical Center
NCT06547632
Methocarbamol vs Oxybutynin for Management of Pain and Discomfort S/P Ureteroscopy Procedure
Northwestern University
NCT05100017
Intravesical Bupivacaine on Post-Operative Ureteroscopy Pain
University of Chicago
NCT06635889
Endogenous Oxalate Synthesis in Idiopathic Calcium Oxalate Kidney Stone Disease
University of Alabama at Birmingham
NCT06989320
Gut Oxalate Absorption in Calcium Oxalate Stone Disease
University of Alabama at Birmingham
NCT06331546
Evaluation of the LithoVue Elite Ureteroscope With Intra-Renal Pressure Monitoring Technology: Examination of Surgeon Behavior and Post-operative Outcomes
University of Kansas Medical Center
NCT06576661
Thulium Fiber Laser (TFL) vs Thulio Pulsed Thulium:YAG (p-Tm:YAG)
University of California, San Diego
NCT06721975
O. Formigenes Colonization in Calcium Oxalate Kidney Stone Disease
University of Alabama at Birmingham
NCT06330246
Evaluation of Genetic Abnormalities Amongst Calcium Phosphate Stone Formers
Ryan L Steinberg
NCT06974357
Ultrasound Imaging of Kidney Stones and Lithotripsy
University of Washington
NCT02214836
SOUND Pivotal Trial - (Sonomotion stOne comminUtion resoNance ultrasounD)
SonoMotion
NCT05701098
Ultrasound First Clinical Decision Support for Suspected Nephrolithiasis
University of California, San Francisco
NCT03461536
Brushite Kidney Stones: A Registry and Database of Clinical and Laboratory Findings
Indiana Kidney Stone Institute
NCT00169663
Hidrate Me Smart Water Bottle Use in Patient With Nephrolithiasis
University of Minnesota
NCT02938884
Use of Oral Probiotics to Reduce Urinary Oxalate Excretion
Mayo Clinic
NCT00587041
Effect of Diet Orange Soda on Urinary Lithogenicity
VA New York Harbor Healthcare System
NCT01330940
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 1 |
| Phase 2 | 1 |
Top Sponsors
Named interventions
Most-linked intervention names on Nephrolithiasis records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Nephrolithiasis trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Nephrolithiasis page
17 registered trials, 10 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 10 Nephrolithiasis trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- University of Alabama at Birmingham sponsors the most Nephrolithiasis trials on record, review their full trial history before evaluating a specific study. See University of Alabama at Birmingham's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Nephrolithiasis condition card totals 17 registered trials; most-linked intervention HidrateSpark Water Bottle; top US site state Illinois. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.